Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters








Year range
1.
Int. j. morphol ; 37(2): 509-514, June 2019. tab, graf
Article in English | LILACS | ID: biblio-1002252

ABSTRACT

Cisplatin is an antineoplastic agent with neuropathy as one of its major side effect. However, effective treatment is lacking. Increasing evidence suggests that cisplatin might damage nerve capillaries leading to impaired functions of blood-nerve barrier (BNB) and neuropathy. This study was aimed to examine the effects of cisplatin on pericytes. Rats were either treated with intraperitoneal injection of cisplatin 2 mg/kg twice a week for five continuous weeks. Cisplatin-treated rats showed reduced body weight, thermal hypoalgesia and slow sciatic motor nerve conduction velocity, indicating neuropathy. The density of pericytes in the distal sciatic nerves determined by immunohistochemistry to desmin was significantly reduced in the cisplatin compared with that of the control groups. Electron microscopic analysis demonstrated the detachment of pericytes from endothelial cells including the disruption of shared basement membrane in the sciatic nerves from cisplatin-treated rats. These data indicate the pericyte loss and detachment caused by cisplatin. Future studies of the BNB components and functions after cisplatin treatment are needed and will be essential for the development of effective treatments against cisplatin-induced neuropathy.


El cisplatino es un agente antineoplásico y presenta como uno de sus principales efectos secundarios, la neuropatía. Sin embargo, falta un tratamiento eficaz. La creciente evidencia sugiere que el cisplatino podría dañar los capilares nerviosos, lo que puede provocar una alteración de las funciones de la barrera hematoencefálica (BHE) y neuropatía. Este estudio tuvo como objetivo examinar los efectos del cisplatino en los pericitos. Las ratas se trataron con inyección intraperitoneal de cisplatino (2 mg/kg) dos veces por semana durante 5 semanas seguidas. Las ratas tratadas con cisplatino mostraron una reducción del peso corporal, hipoalgesia térmica y una velocidad de conducción del nervio ciático lenta, lo que indicaría neuropatía. La densidad de los pericitos en los nervios ciáticos distales determinada por inmunohistoquímica para desmina se redujo significativamente en el grupo cisplatino en comparación con la de los grupos controles. El análisis al microscopio electrónico demostró el desprendimiento de pericitos de las células endoteliales, incluida la ruptura de la membrana basal compartida en los nervios ciáticos de ratas tratadas con cisplatino. Estos datos indican la pérdida de pericitos y el desprendimiento causado por el cisplatino. Se necesitan estudios futuros de los componentes y funciones del BHE después del tratamiento con cisplatino y serán esenciales para el desarrollo de tratamientos efectivos contra la neuropatía inducida por el cisplatino.


Subject(s)
Animals , Male , Rats , Cisplatin/toxicity , Pericytes/drug effects , Nervous System Diseases/pathology , Antineoplastic Agents/toxicity , Body Weight/drug effects , Immunohistochemistry , Rats, Wistar , Pericytes/pathology , Microscopy, Electron, Transmission , Nervous System Diseases/chemically induced
2.
Rev. bras. cir. plást ; 27(3): 487-489, jul.-set. 2012. ilus
Article in Portuguese | LILACS | ID: lil-668156

ABSTRACT

Hemangiopericitomas são tumores raros originados a partir da proliferação de pericitos, ou seja, células que envolvem os capilares. São encontrados em ossos, pulmões, crânio, partes moles profundas ou membros inferiores, principalmente na coxa. É considerado um tumor com potencial de malignidade incerto e quando afeta a região orbitária pode apresentar um comportamento biológico agressivo, com grande chance de recidiva. O objetivo deste trabalho é relatar um caso de hemangiopericitoma orbital e destacar suas características clínicas, cirúrgicas e histopatológicas. Usualmente, os hemangiopericitomas da órbita são tumores sólidos, únicos e de crescimento lento. Devem ser lembrados no diagnóstico diferencial dos tumores orbitários bem delimitados, como cistos epidermoides, schwannomas, neurofibromas, fibro-histiocitomas, lipomas e malformações vasculares. A confirmação diagnóstica é realizada pelo exame anatomopatológico e, por vezes, complementada pelo estudo imuno-histoquímico. O tratamento deve ser realizado com exérese completa do tumor, com margens amplas, sendo a radioterapia e a quimioterapia reservadas para casos de lesões reincidentes.


Hemangiopericytomas are rare tumors arising from the proliferation of pericytes. They may be found in the lungs, bones, skull, deep soft tissue or limbs. The tumor has an unpredictable prognosis and when it affects the orbital region, may have an aggressive behavior, with high incidence of recurrence. We report a case of orbital hemangiopericytoma and highlight clinical, surgical, and histopathological features of these tumors. Orbital hemangiopericytomas usually are solid, slow-growing tumors. They should be considered in the differential diagnosis of well-defined orbital masses along with epidermoid cysts, schwannomas, neurofibromas, fibrous histiocytomas, lipomas, and vascular malformations. The diagnosis is confirmed by anatomopathologic examination and sometimes complemented by immunohistochemistry. Complete excision of the tumor with wide margins is usually curative; however, radiotherapy and chemotherapy may be required for recurrent lesions.


Subject(s)
Humans , Female , Aged , History, 21st Century , Orbit , Surgery, Plastic , Pericytes , Hemangiopericytoma , Neoplasms, Vascular Tissue , Orbit/surgery , Surgery, Plastic/methods , Pericytes/pathology , Hemangiopericytoma/surgery , Hemangiopericytoma/pathology , Neoplasms, Vascular Tissue/surgery , Neoplasms, Vascular Tissue/pathology
3.
Int. j. morphol ; 29(3): 769-781, Sept. 2011. ilus
Article in Spanish | LILACS | ID: lil-608656

ABSTRACT

Las células madre mesenquimales son poblaciones multipotentes de células que tienen amplia capacidad de diferenciación, plasticidad y potencial inmunosupresor, lo que las hace una herramienta de gran importancia en las terapias basadas en células.En función de su potencial, se ha determinado que las células perivasculares poseen características de células madre de gran potencial clínico, no obstante, las propiedades biológicas que llevan a su diferenciación son menos comprendidas. Los últimos avances en la comprensión de la relación entre pericitos y las células madre mesenquimales plantean funciones específicas de tejido, así como, su potencial uso terapéutico en las isquemia, tales como, la cerebro-vascular y un mejor entendimiento de la vascularización patológica tumoral. A pesar de la creciente aceptación que las células perivasculares están relacionada o son células madre mesenquimales, existen escasas pruebas experimentales que muestren la diferenciación de pericitos en diferentes tipos de células (Feng et al., 2010). En esta revisión documentamos los fundamentos biológicos de los pericitos que respaldan su uso en terapia regenerativa.


Mesenchymal stem cells are a multipotent population of cells that have extensive capacity for differentiation, plasticity and immunosuppressive potential, making them an important tool in cell-based therapies. According to their potential, it has been determined that perivascular cells have stem cell characteristics of great clinical potential, however, the biological properties that lead to their differentiation are less understood. Recent advances in understanding the relationship between pericytes and mesenchymal stem cells pose tissue-specific functions, as well as their potential therapeutic use in ischemia, such as cerebro-vascular and a better understanding of the pathological tumor vascularization. Despite the growing acceptance that perivascular cells are related, or that they are mesenchymal stem cells, there is little experimental evidence to show the differentiation of pericytes in different cell types (Feng et al., 2010). In this review we document the biological basis of pericytes that support their use in regenerative therapy.


Subject(s)
Animals , Brain Neoplasms/therapy , Brain Neoplasms/ultrastructure , Pericytes/cytology , Pericytes/pathology , Pericytes/transplantation , Regenerative Medicine/methods
SELECTION OF CITATIONS
SEARCH DETAIL